140 related articles for article (PubMed ID: 33015769)
1. LncRNA SNHG17 promotes proliferation and invasion of ovarian cancer cells through up-regulating FOXA1.
Zheng ZJ; Liu Y; Wang HJ; Pang WW; Wang Y
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9282-9289. PubMed ID: 33015769
[TBL] [Abstract][Full Text] [Related]
2. LncRNA PCAT6 promotes occurrence and development of ovarian cancer by inhibiting PTEN.
Kong FR; Lv YH; Yao HM; Zhang HY; Zhou Y; Liu SE
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8230-8238. PubMed ID: 31646553
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA RP11-552M11.4 promotes cells proliferation, migration and invasion by targeting BRCA2 in ovarian cancer.
Huang K; Geng J; Wang J
Cancer Sci; 2018 May; 109(5):1428-1446. PubMed ID: 29478268
[TBL] [Abstract][Full Text] [Related]
4. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p.
Xu C; Zhu LX; Sun DM; Yao H; Han DX
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1672-1681. PubMed ID: 32141533
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MSTO2P promotes proliferation and autophagy of lung cancer cells by up-regulating EZH2 expression.
Wang LJ; Sun GZ; Chen YF
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3375-3382. PubMed ID: 31081092
[TBL] [Abstract][Full Text] [Related]
6. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
7. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
Xie C; Chen B; Wu B; Guo J; Cao Y
Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
[TBL] [Abstract][Full Text] [Related]
9. Tumour-derived exosome SNHG17 induced by oestrogen contributes to ovarian cancer progression via the CCL13-CCR2-M2 macrophage axis.
Liang H; Geng S; Wang Y; Fang Q; Xin Y; Li Y
J Cell Mol Med; 2024 May; 28(9):e18315. PubMed ID: 38680032
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.
Gong YB; Zou YF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4656-4662. PubMed ID: 31210291
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p/GSK3β pathway in ovarian cancer.
Zhu LM; Li N
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7253-7265. PubMed ID: 32706063
[TBL] [Abstract][Full Text] [Related]
12. LncRNA AFAP1-AS1 promotes proliferation ability and invasiveness of bladder cancer cells.
Gui JQ; Zhang C; Yang HB; Yu YW; Cui MR; Wang WS
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8747-8755. PubMed ID: 32964963
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LINC00152 is up-regulated in ovarian cancer tissues and regulates proliferation and cell cycle of SKOV3 cells.
Ni H; Niu LL; Tian SC; Jing LK; Zhang LT; Lin QQ; Cai YH; Liang HM; Du Q; Li H
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9803-9813. PubMed ID: 31799647
[TBL] [Abstract][Full Text] [Related]
14. LncRNA WTAPP1 promotes proliferation of laryngeal carcinoma cells through regulating microRNA-592.
Shi XY; Lin JJ; Ge XJ; Shi Y
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9532-9540. PubMed ID: 33015795
[TBL] [Abstract][Full Text] [Related]
15. LncRNA FAL1 promotes the development of oral squamous cell carcinoma through regulating the microRNA-761/CRKL pathway.
Ye J; Jiao Y
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5779-5786. PubMed ID: 31298329
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA DANCR upregulates IGF2 expression and promotes ovarian cancer progression.
Gao YQ; Cheng HY; Liu KF
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3621-3626. PubMed ID: 31114986
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA PVT1 functions as an oncogene in ovarian cancer via upregulating SOX2.
Zou MF; Ling J; Wu QY; Zhang CX
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7183-7188. PubMed ID: 30468460
[TBL] [Abstract][Full Text] [Related]
18. LncSNHG14 promotes ovarian cancer by targeting microRNA-125a-5p.
Zhao YL; Huang YM
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3235-3242. PubMed ID: 31081075
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer.
Li J; Huang H; Li Y; Li L; Hou W; You Z
Oncol Rep; 2016 Dec; 36(6):3241-3250. PubMed ID: 27779700
[TBL] [Abstract][Full Text] [Related]
20. LncRNA LUCAT1 promotes proliferation of ovarian cancer cells by regulating miR-199a-5p expression.
Liu HZ; Liu GY; Pang WW; Zhang H; Zeng ZJ; Wang HJ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1682-1687. PubMed ID: 32141534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]